Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Monopar Therapeutics Inc. MNPR

Full chart Compare

Set alert

71.73 USD -0.05 (-0.07%)

At closeNov 12, 2026, 6:27 AM EST

71.10 -0.63 -0.88%

Pre-market · Nov 12, 6:27 AM ET

70.80 Day range 72.87

50.07 52-week range 124.82

YTD: +9.85%
1 year: -14.02%

News

2 days ago globenewswire.com Monopar Presents Data Highlighting Residual Disease Burden in Treatment-Experienced Wilson Disease Patients and Long-Term Molybdenum Safety Data for ALXN1840 at AASLD – The Liver Meeting® 2026 WILMETTE, Ill., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments…